Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Global Stock · Janus Henderson

JFNNX Holdings: What Janus Henderson Global Life Sciences Fund Owns

Ticker JFNNX · · Holdings as of Jun 30, 2026

Expense ratio
0.68%$68/yr per $10k
Net assets
$5.8Ball share classes
Holdings
108

Bottom line

What does JFNNX hold?

JFNNX held 108 positions as of Jun 30, 2026. Its largest holding is Eli Lilly & Co. at 9.41% of the fund, and the top 10 positions add up to 42.4%. By asset type it is 99% stocks, 1% cash & short-term funds.

Updated Aug 26, 2026

JFNNX top 25 holdings

#HoldingType% of fundValue
1 Eli Lilly & Co. Stocks 9.41%$546.4M
2 Johnson & Johnson Stocks 7.09%$411.8M
3 AbbVie, Inc. Stocks 4.67%$271.0M
4 UnitedHealth Group, Inc. Stocks 4.54%$263.6M
5 AstraZeneca plc Stocks 3.93%$228.3M
6 Revolution Medicines, Inc. Stocks 3.02%$175.4M
7 Argenx SE Stocks 2.63%$152.7M
8 Novartis AG Stocks 2.56%$148.8M
9 Thermo Fisher Scientific, Inc. Stocks 2.33%$135.4M
10 Praxis Precision Medicines, Inc. Stocks 2.19%$127.0M
11 Bridgebio Pharma, Inc. Stocks 2.04%$118.5M
12 CVS Health Corp. Stocks 2.02%$117.2M
13 Roche Holding AG Stocks 2.01%$116.9M
14 Intuitive Surgical, Inc. Stocks 1.94%$112.9M
15 Merck & Co., Inc. Stocks 1.87%$108.8M
16 Abbott Laboratories Stocks 1.86%$108.3M
17 Vertex Pharmaceuticals, Inc. Stocks 1.69%$98.3M
18 Ascendis Pharma A/S Stocks 1.68%$97.5M
19 Danaher Corp. Stocks 1.65%$95.7M
20 Amgen, Inc. Stocks 1.64%$95.1M
21 Sanofi SA Stocks 1.58%$91.8M
22 Stryker Corp. Stocks 1.41%$82.0M
23 PTC Therapeutics, Inc. Stocks 1.40%$81.2M
24 Gilead Sciences, Inc. Stocks 1.39%$80.5M
25 Travere Therapeutics, Inc. Stocks 1.38%$80.3M

Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 26, 2026

Asset mix

Stocks99.1%
Cash & short-term funds0.9%

Country exposure

BE0.6%
CA1.2%
CH4.6%
DK1.7%
FR2.0%
GB3.9%
IE1.0%
IL1.1%
KY0.5%
NL2.6%